Search

Your search keyword '"Patel, Bela"' showing total 175 results

Search Constraints

Start Over You searched for: Author "Patel, Bela" Remove constraint Author: "Patel, Bela" Database Unpaywall Remove constraint Database: Unpaywall
175 results on '"Patel, Bela"'

Search Results

4. Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia

6. Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial

12. 840. Risk-Based Screening on Admission Cultures (SOAC) vs. Unit-Wide Reactionary Surveillance Cultures (UWRC) for Candida auris: A Pilot QI Study in a Tertiary Care Center ICU

13. 401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy

14. COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial

15. SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

16. Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

17. Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials

18. A Multicenter Retrospective Cohort Study to Characterize Patients Hospitalized With Multisystem Inflammatory Syndrome in Adults and Coronavirus Disease 2019 in the United States, 2020–2021

19. Efficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function

21. Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial

27. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia

28. COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials

29. Early Treatment, Inflammation and Post-COVID Conditions

30. Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial

32. COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials

33. Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm)

34. Inhibition of Stearoyl-CoA Desaturase Has Anti-Leukemic Properties in Acute Myeloid Leukemia

35. INTERSTITIAL LUNG DISEASE AFTER COVID-19 IN PATIENTS WITH CANCER AND WITHOUT: A PROSPECTIVE COHORT STUDY

38. Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial

39. Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern

43. Early Outpatient Treatment for Covid-19 with Convalescent Plasma

44. How do I implement an outpatient program for the administration of convalescent plasma for COVID ‐19?

45. Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial

46. In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial

48. Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection

Catalog

Books, media, physical & digital resources